Cost-Effectiveness Analysis Of Pertuzumab With Trastuzumab And Chemotherapy Compared To Trastuzumab And Chemotherapy In The Adjuvant Treatment For Patients With Her2-Positive Early Breast Cancer At High Risk Of Recurrence In China
Value in Health(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要